The goal of this project is to understand the mechanism by which the Rho/MLCP (myosin light chain phosphatase) pathway regulates myosin light chain (MLC) phosphorylation and contraction in vascular smooth muscle. In the present proposal, we will clarify the function of p116Rip, the novel regulatory protein of the RhoA/MLCP pathway, based upon our recent findings of this MBS/RhoA binding molecule. While a number of studies have been done on the regulatory role of Rho kinase in smooth muscle, nothing is known about the function of PKN, another RhoA down-stream kinase. Our PRELIMINARY STUDIES raise the possibility that PKN plays a role in the regulation of the RhoA/MLCP pathway, and we will study the function and regulation of PKN in the agonist induced regulation of smooth muscle contraction. Based upon our PRELIMINARY STUDIES, we propose the following hypothesis of the regulatory function of PKN and p116Rip. Upon agonist stimulation, RhoA translocates to the membrane and cytosolic PKN, which has a binding affinity for active RhoA, is recruited to the membrane. PKN becomes activated and sustains the membrane binding of RhoA, thus prolongs RhoA activity. On the other hand, p116Rip associates with myosin and MBS at the actomyosin fiber and activates MLCP reaction, thus facilitating MLC dephosphorylation. P116Rip, at the actomyosin filaments, interacts with cytosolic RhoA to prevent translocation to the membrane, thus attenuating RhoA activation. These effects result in the increase in MLCP activity and down-regulation of MLC phosphorylation in smooth muscle. In this proposal, we will verify this hypothesis. We will first use a siRNA approach to eliminate p116Rip and PKN, respectively, and study the effects of the specific siRNAs in the agonist induced change in MLC20 phosphorylation and muscle contraction. Once we identify the function of p116Rip and PKN in the regulation of MLC20 phosphorylation, we will study the regulatory mechanism of p116Rip and PKN activity. It has been known that the activation of Rho and its downstream molecules are closely related to the translocation of these molecules to the membrane. To further address our hypothesis, we will study the spatio-temporal change in the localization of these molecules after stimulation by using 3D digital imaging analysis of the differentiated smooth muscle cells. To achieve this, we will introduce fluorescent protein (FP)-tagged regulatory proteins using the protein delivery technique. We will also use our newly developed total internal reflection fluorescence (TIRF) microscope to monitor the change in the near-membrane domain of the cells. Furthermore, we will study the binding of p116Rip and PKN with their target molecules by using FRET analysis, thus monitoring the spatio-temporal change in the interaction of the molecules in living cells. The proposed project will clarify the mechanism by which agonists induce vascular smooth muscle contraction, which should provide novel insights into the regulation of vascular constriction and contribute to the pathogenesis of cardiovascular diseases.
Smooth muscle plays an important role in arterial constriction/dilation thus controlling blood pressure and its malfunction causes various vascular diseases such as high blood pressure. In vascular smooth muscle, the external stimuli induce the sustained contraction and this is critical for the prolonged constriction of the blood vessels. The proposed project will clarify the regulatory function of the newly found protein components in the mechanism linking the external stimuli and the contraction of smooth muscle, thus will improve our understanding of vascular constriction and the dilation mechanism.
|Philley, Julie V; Kannan, Anbarasu; Qin, Wenyi et al. (2016) Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression. J Cell Physiol 231:1364-74|
|Tiwari, Nivedita; Marudamuthu, Amarnath S; Tsukasaki, Yoshikazu et al. (2016) p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol 310:L496-506|
|Owens, Shuzi; Jeffers, Ann; Boren, Jake et al. (2015) Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF-?B dependent. Am J Physiol Lung Cell Mol Physiol 308:L1265-73|
|Hosoba, Kosuke; Komatsu, Satoshi; Ikebe, Mitsuo et al. (2015) Phosphorylation of myosin II regulatory light chain by ZIP kinase is responsible for cleavage furrow ingression during cell division in mammalian cultured cells. Biochem Biophys Res Commun 459:686-91|
|Marudamuthu, Amarnath S; Shetty, Shwetha K; Bhandary, Yashodhar P et al. (2015) Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs. J Biol Chem 290:9428-41|
|Shibata, Keita; Sakai, Hiroyasu; Huang, Qian et al. (2015) Rac1 regulates myosin II phosphorylation through regulation of myosin light chain phosphatase. J Cell Physiol 230:1352-64|
|Kwon, Tae-Jun; Oh, Se-Kyung; Park, Hong-Joon et al. (2014) The effect of novel mutations on the structure and enzymatic activity of unconventional myosins associated with autosomal dominant non-syndromic hearing loss. Open Biol 4:|
|Komatsu, Satoshi; Ikebe, Mitsuo (2014) ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms. Am J Physiol Heart Circ Physiol 306:H1275-86|
|An, Byung Chull; Sakai, Tsuyoshi; Komaba, Shigeru et al. (2014) Phosphorylation of the kinase domain regulates autophosphorylation of myosin IIIA and its translocation in microvilli. Biochemistry 53:7835-45|
|Zhang, Cheng-Hai; Lifshitz, Lawrence M; Uy, Karl F et al. (2013) The cellular and molecular basis of bitter tastant-induced bronchodilation. PLoS Biol 11:e1001501|
Showing the most recent 10 out of 24 publications